Pharma Pressreleases

This section covers the managerial aspects in the Pharma industry.

Eiger to Participate in Cowen & Company 2016 Health Care Conference

Monday, February 29, 2016
PR Newswire

PALO ALTO Calif Feb 29 2016 PRNewswire Eiger BioPharmaceuticals Inc announced today plans to participate in the Cowen Company 36th Annual Health Care Conference at the Boston Marriott Copley Place inBoston Massachusetts David Cory the President and CEO of Eiger will present and participate in a..

SELLAS Life Sciences Announces FDA Orphan Drug Designation for WT1 Cancer Vaccine in Patients with Malignant Pleural Mesothelioma

Monday, February 29, 2016
PR Newswire

ZUG Switzerland and NEW YORK Feb 29 2016 PRNewswire SELLAS Life Sciences Group SELLAS a developmentstage biopharmaceutical company focused on innovative products to treat cancers and central nervous system CNS diseases today announced that the US Food and Drug Administration FDA granted orphan dr..

New Pilot Study Finds CosaminĀ® ASU Effective in Reducing Concentrations of Key Biomarkers Associated with Joint Discomfort and Cartilage Breakdown

Monday, February 29, 2016
PR Newswire

EDGEWOOD Md Feb 29 2016 PRNewswire Nutramax Laboratories Consumer Care Inc today announced the results of a sixweek openlabel pilot study that found CosaminASU the companys advanced joint health formulation is effective in reducing concentrations of serum and urine biomarkers associated with joint..

Covalon Announces Strong First Quarter Financial Results

Monday, February 29, 2016
PR Newswire

MISSISSAUGA ON Feb 29 2016 PRNewswire Covalon Technologies Ltd the Company or Covalon TSXV COV an advanced medical technologies company today announced financial results for its first quarter ended December 31 2015 For the three months ended December 31 2015 revenue was 2440633 operating expense..

Valeant Dermatology To Award Scholarships in 2016 to Students and Mothers Pursuing Undergraduate and Graduate Degrees

Monday, February 29, 2016
PR Newswire

BRIDGEWATER NJ Feb 29 2016 PRNewswire Valeant Dermatology a division of Valeant Pharmaceuticals North America LLC today announced the launch of the Valeant Dermatology ASPIRE HIGHER Scholarship Program that will award scholarships of up to 10000 each to nine individual students who will be attend..

AbbVie to Present at Cowen and Company 36th Annual Health Care Conference

Monday, February 29, 2016
PR Newswire

NORTH CHICAGO Ill Feb 29 2016 PRNewswire AbbVie NYSE ABBV will participate in the Cowen and Company 36th Annual Health Care Conference on Wednesday March 9 2016 Richard A Gonzalez chairman and chief executive officer will participate in a question and answer session at 820 am Central time A live ..

Juniper Pharmaceuticals to Present at ROTH Conference on March 14, 2016

Monday, February 29, 2016
PR Newswire

BOSTON Feb 29 2016 PRNewswire George Elston Chief Financial Officer of Juniper Pharmaceuticals IncNasdaq JNP Juniper or the Company will present at the 28th Annual ROTH Conference in Dana Point CA on Monday March 14 2016 at 900 am Pacific Time 1200 pm Eastern Time in Salon 5 Mr Elston will be join..

MarketResearch.com: 4 Life Science White Papers to Download

Monday, February 29, 2016
PR Newswire

WASHINGTONand NEW YORK and LONDON Feb 29 2016 PRNewswire MarketResearchcom published a blog post promoting four life science white papers that are available for free download To learn more visit our blog httphubslyH02c3gn0 In partnership with Kalorama Information MarketResearchcom has publis..

Trovagene Schedules Release of Fourth Quarter and Year End 2015 Financial Results and Investor Conference Call

Monday, February 29, 2016
PR Newswire

SAN DIEGO Feb 29 2016 PRNewswire Trovagene Inc NASDAQ TROV a developer of cellfree molecular diagnostics announced today that it will report financial results for the fourth quarter and the year ended December 31 2015 on Thursday March 10 2016 at 400 pm Eastern Standard Time 100 pm Pacific Standa..

Tikcro Opens Offices and Lab at Kiryat Weizmann Science Park in Israel

Monday, February 29, 2016
PR Newswire

TEL AVIV Israel Feb 29 2016 PRNewswire Tikcro Technologies OTCQX TIKRF a developer of next generation antibodies for immune modulators cancer treatment announced today the opening of its new offices and lab at theKiryat Weizmann Science Park in Ness ZionaIsrael Since 2014 Tikcro has been develop..

CytRx to Present at the Cowen & Company\'s 36th Annual Health Care Conference

Monday, February 29, 2016
PR Newswire

LOS ANGELES Feb 29 2016 PRNewswire CytRx Corporation NASDAQ CYTR a biopharmaceutical research and development company specializing in oncology today announced that David Haen Vice President of Business Development and Investor Relations will present a corporate update at Cowen and Companys 36th A..

DiscoverX and the SGC Partner to Make an Annotated Collection of >600 Kinase Inhibitors Freely Available

Monday, February 29, 2016
PR Newswire

FREMONT Calif Feb 29 2016 PRNewswire DiscoverX Corporation the leading supplier of innovative cellbased assays and services for drug discovery and development today announced its partnership with the Structural Genomics Consortium SGC a publicprivate organization established in 2003 to develop se..

Quest Diagnostics Completes Acquisition of Clinical Laboratory Partners\' Outreach Laboratory Service Business in Connecticut

Monday, February 29, 2016
PR Newswire

MADISON NJand HARTFORD Conn Feb 29 2016 PRNewswire Quest Diagnostics NYSE DGX the worlds leading provider of diagnostic information services today announced it has completed its previously announced acquisition of the outreach laboratory service business of Clinical Laboratory Partners CLP a whol..

Naval Medical Center San Diego Joins StemCutis Photoaging Clinical Trial Using Allogeneic Mesenchymal Stem Cells

Monday, February 29, 2016
PR Newswire

SAN DIEGO Feb 29 2016 PRNewswire StemCutis LLC a subsidiary of Stemedica Cell Technologies Inc today announced the addition of the Naval Medical Center San Diego NMCSD as a second site for the Phase II portion of its clinical trial for subjects with cutaneous photoaging a skin condition caused by ..

Spero Therapeutics to Present at Cowen and Company 36th Annual Health Care Conference

Monday, February 29, 2016
PR Newswire

CAMBRIDGE Mass Feb 29 2016 PRNewswire Spero Therapeutics a biopharmaceutical company founded to develop novel therapies to treat bacterial infections announced today that Ankit Mahadevia President and CEO will present a company overview at the Cowen and Company 36th Annual Health Care Conference ..

Peregrine Alert -- National Securities Law Firm Continues Investigation of Peregrine Pharmaceuticals, Inc. for Potential Securities Law Claims, and Encourages Shareholders With Losses in Excess of $50,000 to Contact the Law Firm for More Information

Monday, February 29, 2016
PR Newswire

NEW YORK Feb 29 2016 PRNewswire Tripp Levy PLLC a leading national securities law firm is investigating possible securities fraud claims involving Peregrine Pharmaceuticals Inc NASDAQ PPHM PPHMP Peregrine or the Company Peregrine is a biopharmaceutical company based in Tustin California that dev..

Regeneron Announces Upcoming 2016 Investor Conference Presentation

Monday, February 29, 2016
PR Newswire

TARRYTOWN NY Feb29 2016 PRNewswire Regeneron Pharmaceuticals Inc NASDAQ REGN will webcast a management presentation at the following investor conference Barclays Global Healthcare Conference at 1015 am Eastern Time on Wednesday March 16 2016 The session may be accessed through the Companys web ..

Apervita Selected by GE Healthcare to Help Expand its Advanced Analytics Footprint

Monday, February 29, 2016
PR Newswire

CHICAGO Feb 29 2016 PRNewswire Apervita Inc the fastest growing platform and marketplace for creating distributing and scaling health analytics and data announced GE Healthcare is working with Apervita to make its advanced analytics application DenialsIQ available through the Apervita marketplace..

Q BioMed Inc. CEO Provides Corporate Overview in an Interview With Scrip Intelligence

Monday, February 29, 2016
PR Newswire

NEW YORK February 29 2016 PRNewswire Q BioMed Inc OTCQB QBIO a biotechnology acceleration company is pleased to share the recently published video interview from the Biotech Showcase conference which took place in San Francisco in January 2016 In the video CEO Denis Corin is interviewed by Mike..

Bone Biologics Completes $5.75 Million Round Of Financing

Monday, February 29, 2016
PR Newswire

BOSTON Feb 29 2016 PRNewswire Bone Biologics OTCQB BBLG an orthobiologic company focused on regenerative medicine announced today the completion of a 575 million funding round with Musculoskeletal Transplant Foundation OrthoFix Holdings Inc and Hankey Capital LLC Proceeds will be used primarily to..

TOP